Wikidata

(Q33183439)

English

Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity

scientific article

In more languages

Statements

title
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
author name string
Diederik F S Kehrer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
Annelies M Bos
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
Walter J Loos
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
Maja J A de Jonge
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
Marta Hamilton
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
Terri Cameron
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
Elisabeth G E de Vries
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017
page(s)
1222-1231
1 reference
stated in
Europe PubMed Central
PubMed ID
11870164
retrieved
23 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33183439&oldid=2022638263"